La Mesa, CA, United States of America

Gnel M Mkrtchyan

This inventor holds 1 USPTO granted patent. Top assignee: Sangart, Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gnel M Mkrtchyan. Retrieved from https://idiyas.com/inventor/gnel-m-mkrtchyan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gnel M Mkrtchyan: Innovator in Hemoglobin-Based Oxygen Carriers

Introduction

Gnel M Mkrtchyan is a notable inventor based in La Mesa, California. He has made significant contributions to the field of biomedical engineering, particularly in the development of oxygen delivery systems. His innovative approach has led to advancements in how oxygen is transported to tissues in the body.

Latest Patents

Gnel Mkrtchyan holds a patent for a "Method for making polyalkylene oxide modified hemoglobin." This invention presents a method for preparing a hemoglobin-based oxygen carrier designed to deliver oxygen effectively to tissues. The process involves mixing deoxygenated hemoglobin with a maleimide-activated polyalkylene oxide (PAO) to create an oxygen-carrying product. This product is characterized by having 2 to about 8 PAO moieties covalently bound to deoxygenated hemoglobin, with a p50 value that is less than that of native stroma-free hemoglobin from the same animal source when measured under identical conditions.

Career Highlights

Gnel Mkrtchyan has been instrumental in advancing the science of oxygen carriers. His work at Sangart, Inc. has positioned him as a key figure in the development of innovative medical solutions. His research focuses on improving the efficacy of oxygen delivery, which is crucial for various medical applications.

Collaborations

Gnel has collaborated with notable professionals in his field, including Kim D Vandegriff and Ashok Malavalli. These collaborations have further enhanced the research and development of hemoglobin-based therapies.

Conclusion

Gnel M Mkrtchyan's contributions to the field of hemoglobin-based oxygen carriers demonstrate his commitment to innovation in medical science. His patented methods and collaborative efforts continue to pave the way for advancements in oxygen delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…